Skip to content
Sign in
European CDMOs compared · 2026 census

CDMOs in Bulgaria: 3 compared (2026)

3 of the 255 contract development and manufacturing organisations in A4BEE’s European census are headquartered in Bulgaria. The largest, with revenue over €1bn, are Biovet (Huvepharma) and Sopharma. 0 sit between €250m and €1bn and 1 are smaller or niche.

By ownership: 2 family-owned and 1 listed. The most common capabilities are small-molecule API (2), oral solid dose (2), microbial and protein (1) and sterile fill-finish (1). 2 of the 3 rows rest on audited reports or official company disclosures; the rest come from secondary sources or estimates.

Open these 3 in the interactive mapAll 255 European CDMOs

3 companies

CDMOs in Bulgaria

CompanyHQOwnershipSizeRevenue (as reported)ModalitiesData
Biovet (Huvepharma)Huge fermentation platform — mainly own animal-health APIs but offers custom synthesis/fermentation and human-health APIs. CDMO relevance is microbial API.PeshteraFamily-ownedHuvepharma / Domuschiev familyTier 1not disclosedMicrobial and protein, Small-molecule APIlow
SopharmaListed Bulgarian pharma with a dedicated CDMO business unit: sterile/non-sterile liquids, oral solids/semi-solids, API, packaging/serialization; handles controlled substances.SofiaListedTier 1not disclosedOral solid dose, Sterile fill-finish, Small-molecule APIhigh
AdipharmPrivately-owned Bulgarian full-service CMO for solid dosage, semi-solids and oral liquids (dev, bulk, packaging incl. serialization). New €3.6M site (2022).SofiaFamily-ownedTier 3not disclosedOral solid dosehigh

Size: Tier 1 (revenue over €1bn) · Tier 2 (€250m–€1bn) · Tier 3 (under €250m or niche).

Revenue, staff and site figures are as reported and mix audited accounts with commercial estimates, which are often wrong for private companies. Each row carries a confidence mark; verify a figure before quoting it.

Browse the census

Other European CDMO lists